Citation Impact
Citing Papers
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Subpolar addition of new cell wall is directed by DivIVA in mycobacteria
2014 StandoutNobel
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
How can immunology contribute to the control of tuberculosis?
2001
A novel cell surface trans-sialidase of trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells
1991
Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells
2009
Inhibition of cruzipain visualized in a fluorescence quenched solid-phase inhibitor library assay.D-Amino Acid Inhibitors for cruzipain, cathepsin B and cathepsin L
1998 StandoutNobel
Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays
1999
Proteolytic Activity of Human Osteoclast Cathepsin K
1996
Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors
2014
Mechanism and medical implications of mammalian autophagy
2018 Standout
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope
1999
Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities
2006
Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense
2001
Glycosylinositol Phospholipid Anchors of the Scrapie and Cellular Prion Proteins Contain Sialic Acid
1992 StandoutNobel
Cruzipain, a majorTrypanosoma cruziantigen, conditions the host immune response in favor of parasite
2002
Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
2013
Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis
2011 StandoutNobel
Understanding the mechanism of action of bacterial superantigens from a decade of research
1999
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Differences in substrate specificities between cysteine protease CPB isoforms of Leishmania mexicana are mediated by a few amino acid changes
2004 StandoutNobel
The role of pro regions in protein folding
1993 StandoutNobel
Intermediate metabolism inTrypanosoma cruzi
1994
SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis
2003
Trehalose Is Required for Growth of Mycobacterium smegmatis
2004 StandoutNobel
Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age Children
2002 Standout
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
2007 Standout
Autophagy in Human Health and Disease
2013 Standout
Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein
2002
Expression and Efficient Export of Enzymatically ActiveMycobacterium tuberculosis Glutamine Synthetase in Mycobacterium smegmatis and Evidence That the Information for Export is Contained within the Protein
1997
Substrate Recognition, Protein Dynamics, and Iron-Sulfur Cluster in Pseudomonas aeruginosa Adenosine 5′-Phosphosulfate Reductase
2006 StandoutNobel
A yeast gene (BLH1) encodes a polypeptide with high homology to vertebrate bleomycin hydrolase, a family member of thiol proteinases
1993
Autophagy and Aging
2011 Standout
Leprosy
2004 Standout
Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana
2000 StandoutNobel
A Riboswitch-Based Inducible Gene Expression System for Mycobacteria
2012 StandoutNobel
Kinetic measurements and mechanism determination of Stf0 sulfotransferase using mass spectrometry
2005 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages
2004 Standout
Amoebiasis
2003 Standout
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
2003
Probing the Mycobacterial Trehalome with Bioorthogonal Chemistry
2012 StandoutNobel
Structural determinants of specificity in the cysteine protease cruzain
1997
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity
1997
Novel Mitochondrial Complex II Isolated from Trypanosoma cruzi Is Composed of 12 Peptides Including a Heterodimeric Ip Subunit
2009 StandoutNobel
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
2000 StandoutNature
A target within the target: probing cruzain’s P1′ site to define structural determinants for the Chagas’ disease protease
2000
The immunopathogenesis of sepsis
2002 StandoutNature
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides
1997 StandoutNobel
Immunology of Tuberculosis
2001 Standout
Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis
1998
Mycobacterium and the coat of many lipids
2002
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
1993 Standout
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry
2004 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Synthetic Analogues of Glycosylphosphatidylinositol-Anchored Proteins and Their Behavior in Supported Lipid Bilayers
2007 StandoutNobel
Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target
1999
Identification and Characterization of the ESAT-6 Homologue ofMycobacterium lepraeand T-Cell Cross-Reactivity withMycobacterium tuberculosis
2002
Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometry
2003
Cysteine Proteinases and the Pathogenesis of Amebiasis
2000
Advances in leishmaniasis
2005 Standout
A sulfated metabolite produced bystf3negatively regulates the virulence ofMycobacteriumtuberculosis
2006 StandoutNobel
Disruption of the Genes Encoding Antigen 85A and Antigen 85B of Mycobacterium tuberculosis H37Rv: Effect on Growth in Culture and in Macrophages
2000
Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State
2008 StandoutNobel
Nonreplicating Persistence ofMycobacteriumTuberculosis
2001
The tuberculosis epidemic. Scientific challenges and opportunities.
1998
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
The Twin-Arginine Translocation Pathway of Mycobacterium smegmatis Is Functional and Required for the Export of Mycobacterial β-Lactamases
2005
Genetic requirements for mycobacterial survival during infection
2003 Standout
The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin.
1996
The rv1184c Locus Encodes Chp2, an Acyltransferase in Mycobacterium tuberculosis Polyacyltrehalose Lipid Biosynthesis
2014 StandoutNobel
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis
1997 Science
PapA1 and PapA2 are acyltransferases essential for the biosynthesis of theMycobacterium tuberculosisvirulence factor Sulfolipid-1
2007 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
A new evolutionary scenario for the Mycobacterium tuberculosis complex
2002 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi.
1993
SPOCC: A Resin for Solid-Phase Organic Chemistry and Enzymatic Reactions on Solid Phase
1999 StandoutNobel
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin.
1991
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors
1998
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Role of Protein Kinase G in Growth and Glutamine Metabolism of Mycobacterium bovis BCG
2005
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae
1997
Cysteine Protease B of Leishmania mexicana Inhibits Host Th1 Responses and Protective Immunity
2003
Works of G Harth being referenced
Distribution and Expression of Toxic Shock Syndrome Toxin 1 Gene Among Staphylococcus aureus Isolates of Toxic Shock Syndrome and Non-Toxic Shock Syndrome Origin
1989
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG
2005
Immunocytochemical localization of neuraminidase in Trypanosoma cruzi
1990
Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies
1989
The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi.
1992
Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis
1996
High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets
1997
Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity.
1994
Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.
1995
Neuraminidase from Trypanosoma cruzi: analysis of enhanced expression of the enzyme in infectious forms.
1987